|
|
|
Vol. 14, No. 4, pp. 397-402, February 15, 2000
California Institute of Technology, Division of Biology, Pasadena, California 91125 USA
| |
Abstract |
|---|
|
|
|---|
Although a small decrease in survival and increase in tumor
incidence was observed in ATR+/
mice, ATR
/
embryos die early in
development, subsequent to the blastocyst stage and prior to 7.5 days
p.c. In culture, ATR
/
blastocysts cells continue to cycle into mitosis for 2 days but subsequently fail to expand and die of caspase-dependent apoptosis. Importantly, caspase-independent chromosome breaks are observed in
ATR
/
cells prior to widespread
apoptosis, implying that apoptosis is caused by a loss of genomic
integrity. These data show that ATR is essential for early embryonic
development and must function in processes other than regulation of p53.
| |
Introduction |
|---|
|
|
|---|
ATM and ATR are mammalian counterparts to a family of
high molecular weight protein kinases conserved in a
broad range of species including Schizosaccharomyces pombe,
Saccharomyces cerevisiae, and Drosophila melanogaster
(Keith and Schreiber 1995
; Keegan et al. 1996
; Cimprich et al. 1996
;
Canman et al. 1998
). The genes most closely related to ATM and
ATR are the MEC1 (S. cerevisiae) TEL1 (S. cerevisiae), RAD3 (S. pombe), and Mei-41 (D. melanogaster) genes. Each
of these genes is involved in DNA damage responses and falls into two
groups based both on homology and function. ATM is related
most closely to TEL1, a gene that shares an overlapping role
with MEC1 in checkpoint responses to
-irradiation in
S. cerevisiae (Morrow et al. 1995
). ATR, on the other
hand, is most closely related to RAD3, Mei-41, and
MEC1 in descending order of similarity. The kinase domain of
ATR is 61% and 53% identical to the kinase domains of
RAD3 and Mei-41, respectively (Keith and Schreiber
1995
; Cimprich et al. 1996
; Keegan et al. 1996
), whereas the
ATM kinase domain shares only 39% identity with either RAD3 or Mei-41.
Recent studies indicate that ATR functions in DNA damage
response pathways similar to those mediated by RAD3, Mei-41, and MEC1.
RAD3, Mei-41, and MEC1 are required for
checkpoint responses to pyrimidine dimer formation (UV radiation),
DNA-alkylation (MMS), depletion of deoxyribonucleotides [hydroxyurea
(HU)] and
-irradiation (Weinert et al. 1994
; Hari et al. 1995
;
Bentley et al. 1996
). In addition to cell cycle checkpoint response,
these genes have been implicated in the regulation of DNA repair
(Weinert 1998
). Consistent with the hypothesis that ATR is the
functional mammalian homolog of RAD3, Mei-41, and
MEC1, expression of a kinase inactive mutant of ATR
(ATR-KI) sensitizes mammalian cells to these same forms of DNA damage
and diminishes the G2/M checkpoint response induced by
-irradiation (Cliby et al. 1998
; Wright et al. 1998
). Recently, this ATR-KI cell line has been shown to be deficient in the
regulated phosphorylation of p53 in response to UV and
-irradiation (Tibbetts et al. 1999
). Because
ATM-disrupted cells are deficient in regulating p53 levels in
response to
-irradiation but not in response to UV or MMS (Canman
et al. 1994
; Xu and Baltimore 1996
), ATR and ATM may possess both
overlapping and nonredundant roles in regulating p53 (Canman et al.
1998
; Tibbetts et al. 1999
).
Here, we describe the phenotype of mice deficient in ATR.
Whereas ATR+/
mice display a small
decrease in survival and increase in tumor incidence,
ATR
/
embryos die early in
development. Early embryonic lethality and observations of
ATR
/
blastocysts cultured in
vitro indicate that ATR has an essential role in the
proliferation of early embryonic cells. In addition, we show that
ATR
/
cultured blastocyst cells
suffer chromosomal fragmentation, suggesting that that the early death
of ATR
/
embryos is caused by a
widespread loss of genomic integrity. Because
ATM
/
and
p53
/
mice do not display a
similar phenotype, these data indicate that ATR must function in some
manner that is not redundant with ATM and is independent of
p53 regulation. Evidence in support of a role for ATR in regulation of
the BRCA gene products and in S- to M-phase transition of
early embryonic cells is discussed.
| |
Results |
|---|
|
|
|---|
ATR disruption
Targeted disruption of ATR was achieved by deletion of
three exons encoding the translation initiating methionine and the following 90 amino acids (Fig. 1A). Homologous
recombination of the targeting vector into the ATR gene
introduces a neomycin resistance cassette containing a single
EcoRV site (Fig. 1A). This EcoRV site was
subsequently used for colony screening by Southern blot (Fig. 1B) and
the genotype of positive clones was confirmed further by PCR (Fig. 1C).
Chimeric mice originating from three different ES cell clones
transmitted the ATR disruption to F1 offspring. Although quantitation of ATR mRNA in homozygous
ATR-disrupted cells was not possible due to early embryonic
lethality (below), ES cells and murine embryonic fibroblasts (MEFs)
with a single ATR allele disrupted expressed 47% ± 7%
(95% confidence interval) and 46% ± 10% less ATR mRNA,
respectively (Fig. 1D). Truncated mRNA species in
ATR+/
cells were not observed
(Fig. 1D). Preliminary analysis of the effects of MMS, cisplatin,
-irradiation, and HU on heterozygous ES cells and MEFs showed no
significant differences in the survival of
ATR+/+ and
ATR+/
cells (data not shown).
|
Increase in tumor incidence in
ATR+/
mice
Although p53+/
mice exhibit
decreased longevity and increased tumor incidence (Jacks et al. 1994
),
ATM+/
mice survive similarly to
wild-type mice (Barlow et al. 1999
; C. Barlow, pers. comm.). Because
ATR and ATM are speculated to have both overlapping
and nonredundant roles in regulating p53, we asked whether the
longevity of ATR+/
mice is
compromised. ATR+/
and
ATM+/
mice (Xu and Baltimore 1996
)
were crossed to produce populations of
ATR+/
,
ATR+/
ATM+/
,
and ATM+/
mice. Although no
difference was observed in the survival of ATR+/
mice in comparison to
ATR+/
ATM+/
mice, a decrease in the survival of both
ATR+/
and
ATR+/
ATM+/
mice was observed in comparison to that of
ATM+/
mice. By 18 months, 10 of 48 ATR+/
(21%) and 8 of 41 ATR+/
ATM+/
mice (20%) had died in comparison to 1 of 22 ATM+/
mice (4.5%). Of the 10 ATR+/
and
ATR+/
ATM+/
mice autopsied postmortem, 6 had evident tumors. The types of tumors
observed were histiocytic sarcoma (one in
ATR+/
; two in
ATR+/
ATM+/
),
large follicular center cell lymphoma
(ATR+/
), gastric adenoma
(ATR+/
ATM+/
),
and sebaceous gland adenoma
(ATR+/
).
To further examine the tumor incidence in these mice, autopsies were
performed on the remaining ATR+/
,
ATR+/
ATM+/
,
and ATM+/
mice at 79-89 weeks of
age [mean age = 83 ± 3 (S.D.) weeks]. In comparison
to ATM+/
mice, a 4- and 2.6-fold
increase in tumor incidence was observed in
ATR+/
and
ATR+/
ATM+/
mice, respectively. In total, 5 of 25 ATR+/
mice (20%), 4 of 30 ATR+/
ATM+/
mice (13%), and 1 of 21 ATM+/
mice (4.8%) had obvious tumors ranging from 1 to 3 cm in diameter. Comparison of the tumor incidence in
ATM+/
mice with that observed in
ATR+/
mice and in
ATR+/
and
ATR+/
ATM+/
mice combined was significant to P values of 0.050 and 0.045, respectively. The types of tumors observed were plasma cell lymphoma (ATM+/
), mixed follicular center
cell lymphoma (two in ATR+/
; two
in
ATR+/
ATM+/
),
hepatocellular adenoma (one in
ATR+/
; one in
ATR+/
ATM+/
),
fibrous histiocytoma (ATR+/
),
ovarian cystadenoma (ATR+/
), and
ovarian fibroma
(ATR+/
ATM+/
).
Although Southern blot analysis of DNA extracted from
ATR+/
and
ATR+/
ATM+/
tumors did not indicate a loss of heterozygosity at the targeted region
of ATR (data not shown), it is possible that alterations outside the targeted region may have occurred in these tumors given the
large size of the ATR genomic locus (>60 kb). Together, these results indicate that in contrast to heterozygosity of the ATM gene, ATR heterozygosity causes a small decrease
in survival and increase in tumor incidence.
ATR is required for early embryonic cellular proliferation
To generate homozygous ATR-disrupted mice,
ATR+/
mice were intercrossed.
However, of 225 progeny analyzed, no homozygous ATR-disrupted pups were observed, implying that ATR is essential for
embryonic development. The stage at which
ATR
/
embryos arrest in
development was then determined by isolation of embryos from time-mated
heterozygous crosses (Table 1). Although an
abnormally high number of decidua contained embryos in the final stages
of resorbtion, no viable ATR
/
embryos were observed at day 7.5 postcoitum (p.c.) or beyond. (Table
1). The high number of resorbed embryos, however, suggested that
ATR
/
embryos survive earlier
stages of development and die following implantion. To test whether
ATR
/
embryos survive to the
blastocyst stage, embryos were isolated 3.5 days p.c. and genotyped. Of
83 embryos genotyped, 20 were ATR
/
. Thus,
ATR
/
embryos successfully
develop to the blastocysts stage but die subsequently, prior to E7.5.
|
To determine if the developmental defect in
ATR
/
mice was due to an
inability of cells to proliferate subsequent to the blastocyst stage,
day 3.5 embryos were isolated from
ATR+/
intercrosses and grown in
culture for 6 days. After 1 day in culture,
ATR+/+,
ATR+/
, and
ATR
/
blastocysts hatched from
the zona pellucida and implanted onto the tissue culture plastic. At
isolation and during the first 2 days in culture, the inner cell mass
(ICM) of ATR
/
blastocysts was
indistinguishable from that of ATR+/+
and ATR+/
blastocysts. However,
while the ICM cells of ATR+/+ and
ATR+/
embryos continued to expand
throughout the 6-day culture period, ATR
/
ICM cells failed to
expand subsequent to day 2 and invariably died by day 4 in culture
(Fig. 2A). Only the nondividing trophoblastic giant
cells (TGC) of ATR
/
embryos
remained after 6 days in culture (Fig. 2A). Identical results were
observed with ATR
/
blastocysts
(n = 8) derived from an independent ATR-disrupted line (line 2, data not shown).
|
The timing and cause of ATR
/
ICM cell death was then explored by TUNEL staining of blastocysts
placed in culture for 48 or 72 hr. TUNEL staining detects extensive DNA
fragmentation that results from apoptotic cell death. Although few
TUNEL-stained cells were observed in
ATR
/
blastocysts cultured for
48 hr, widespread TUNEL staining was observed after 72 hr (Fig. 2B). A
majority of the TUNEL-stained ATR
/
cells was confirmed to be
due to apoptosis through the use of the caspase 3-inhibitor Z-DEVD-FMK
(Longthorne and Williams 1997
). Caspase-3 is a protease required for
initiation of apoptotic chromosome fragmentation following exposure of
ES cells and other cell types to a vast array of DNA-damaging agents
(Woo et al. 1998
). The potent inhibitor of caspase-3, Z-DEVD-FMK, has
been shown to inhibit Fas-induced apoptosis in T cells (Longthorne and
Williams 1997
). As shown, preincubation of
ATR
/
blastocyst cells with
Z-DEVD-FMK inhibited the TUNEL staining observed after 48 and 72 hr of
culture (Fig. 2B). Overall, the number of TUNEL-stained cells in
ATR
/
blastocysts was reduced
80% by preincubation with Z-DEVD-FMK. Consistent with caspase-3
knockout studies (Woo et al. 1998
), Z-DEVD-FMK did not rescue
ATR
/
cells from other
morphological effects of apoptosis such as changes in nuclear
morphology (Fig. 2B, day 3). These results demonstrate that
ATR is essential for expansion of early embryonic cells in culture and that loss of ATR ultimately results in apoptotic
cell death.
Chromosome fragmentation in
ATR
/
cells
Given the potential role of ATR in DNA replication and damage
checkpoints and DNA repair, we speculated that the apoptotic signal in
ATR
/
ICM cells may be
initiated by damaged DNA resulting from the lack of ATR. If
so, one would expect that such damage would occur equally in the
presence and absence of Z-DEVD-FMK. To examine this possibility,
mitotic spreads were prepared from blastocysts grown for 48 hr in
culture and then treated with nocodazole or left untreated for 6 hr.
The number of mitotic cells in
ATR
/
blastocyst cultures
increased significantly upon treatment with nocodazole, indicating that
ATR
/
cells attempt
proliferation at day 2 in culture (Table 2). However, consistent with the hypothesis that disruption of ATR causes a loss of genomic integrity, chromosomal fragmentation was apparent in
>60% of the mitotic spreads from
ATR
/
cells and appeared
equally with or without Z-DEVD-FMK pre-incubation (Table 2). Thus, the
Z-DEVD-FMK-resistant chromosomal fragmentation observed in
ATR
/
blastocysts at day 2 in
culture (Fig. 3) correlates to and is the likely
cause of the widespread caspase-dependent apoptosis observed at day 3 (Fig. 2B). As shown, chromosome fragmentation ranged from mild (Fig.
3A) to extensive (Fig. 3B). This extensive mitotic DNA fragmentation
(Fig. 3B) may contribute to the residual caspase-independent TUNEL
staining observed in the presence of Z-DEVD-FMK (discussed above);
however, the degree of fragmentation observed in a majority of mitotic
spreads was apparently beyond the limits of detection by TUNEL.
Although we cannot rule out the possibility that the observed
chromosome fragmentation in ATR
/
cells may result from
early stages of a caspase-independent apoptotic process, these data are
consistent with the hypothesis that the aborted development of
ATR
/
embryos results from a
loss of genomic integrity.
|
|
| |
Discussion |
|---|
|
|
|---|
We have found that disruption of the ATR gene leads to a
small increase in tumorigenesis in heterozygotes and very early
embryonic lethality in homozygotes. Although the total incidence of
tumors in ATR heterozygotes was not as great as those observed
in p53 heterozygotes (Jacks et al. 1994
), the effect of
ATR heterozygosity was statistically significant. It is
interesting to note that the incidence of large benign tumors was
particularly increased in ATR heterozygotes. This increase in
benign tumors may indicate that deficiency in ATR has a
greater effect on the rate of tumor initiation than on the rate of
progression to malignancy. It is currently not known whether
ATR defects exist in humans; however the region to which
ATR maps in humans is a site of genetic alteration in lung
cell carcinomas (Cimprich et al. 1996
)
As described here, our data indicate that ATR has an essential role in
preventing the occurrence of DNA damage early in embryogenesis. Although recent studies suggest that ATR regulates p53, defective regulation of p53 is unlikely to be the sole cause of such DNA damage,
as p53
/
mice do not suffer a
block in early embryonic development similar to that observed in
ATR
/
mice. Based on previous
studies and data provided in this paper, two plausible essential roles
for ATR are apparent and are discussed here: regulation of the
BRCA gene products and control of the S- to M-phase transition.
BRCA1 and BRCA2 regulation
Several lines of evidence have substantiated a link between ATR
and the functions of BRCA1 and BRCA2.
BRCA1
/
,
BRCA2
/
, and
RAD51
/
mice die early in
development and have cellular proliferation defects similar to that
observed in ATR
/
cultured
blastocysts (Hakem et al. 1996
; Lim and Hasty 1996
; Sharan et al. 1997
;
Suzuki et al. 1997
). Secondly, like
ATR
/
cells, chromosome breaks
are observed in RAD51
/
,
BRCA1 exon 11-deleted, and BRCA2-truncated cells (Lim
and Hasty 1996
; Patel et al. 1998
; Xu et al. 1999
). Finally, the
ATR homolog ATM recently has been shown to be
required for the phosphorylation of BRCA1 in response to
-irradiation but is dispensable for BRCA1 phosphorylation in
response to HU, MMS, and UV (Scully et al. 1997
; Cortez et al. 1999
).
Because ATR-KI expression renders cells sensitive to these later
reagents (Cliby et al. 1998
; Wright et al. 1998
), it is possible that
ATR and ATM both regulate BRCA1 phosphorylation, albeit in a DNA
damage-specific manner. These genetics and biochemical similarities
provide correlative evidence that the BRCA gene products may
be dependent on ATR function.
S- to M-phase transition
A second plausible essential function for ATR is suggested by the
similarity between the extensive chromosomal fragmentation in
ATR
/
cells (Fig. 3B) and that
observed in cells undergoing mitotic catastrophe. Mitotic catastrophe
is caused by premature entry of cells into mitosis prior to completion
of DNA synthesis and is characterized by a high degree of chromosomal
fragmentation (Heald et al. 1993
; Schlegel and Pardee 1986
). The
treatments and mutations that cause mitotic catastrophe are now
recognized to influence a pathway that regulates DNA damage and
replication checkpoints in mammalian cells and S. pombe (Heald
et al. 1993
; Russell 1998
; Chan et al. 1999
; Pines 1999
). Importantly,
in S. pombe this pathway requires RAD3, the closest
known relative of ATR (Cimprich et al. 1996
; Keegan et al.
1996
). Although recent studies indicate ATR may have a redundant role
with ATM in regulating this checkpoint pathway in response to
-irradiation (Cliby et al. 1998
; Matsuoka et al. 1998
; Chaturvedi
et al. 1999
), an essential role for ATR in DNA replication checkpoint
responses has been implied (Cliby et al. 1998
; Chaturvedi et al. 1999
;
Sarkaria et al. 1999
).
If ATR regulates a DNA replication checkpoint in mammalian cells,
mitotic catastrophe in ATR
/
cells might be due to the lack of such a checkpoint combined with the
extremely rapid cellular proliferation that occurs normally in the
course of early embryonic development. Early embryonic cells
proliferate with doubling times as short as 2 hr at day 6.5 p.c. (Snow
1977
) and can completely lack a G2 phase (Aladjem et al.
1998
). Such rapid proliferation indicates a high degree of precision in
transition from S to M phase. Thus, the chromosomal fragmentation in
ATR
/
cells might be due to an
inability to coordinate this transition accurately, resulting in
premature entry into mitosis. According to this analysis, ATR may be
dispensable in cells that cycle through a more extensive G2
phase, but might be particularly essential in the early embryo to sense
incomplete DNA replication and prevent mitotic catastrophe.
| |
Materials and methods |
|---|
|
|
|---|
Generation of the ATR targeted allele
A 17-kb genomic fragment encoding the amino terminus of murine
ATR was cloned from a 129SVJ genomic library (Stratagene). The
ATR targeting vector was constructed by subcloning the 2.9-kb SalI and 7.5-kb XbaI genomic fragments flanking the
6.5-kb ATR amino terminal encoding fragment into the pPNT
vector (Fig. 1A). ATR-disrupted ES cells cells were generated
in both D3 and J1 lines. A single targeted allele was observed in 9 of
310 isolated ES cell colonies. Isolated colonies were expanded and DNA
was prepared by digestion in PK buffer (100 mM Tris at pH
8.0, 400 mM NaCl, 5 mM EDTA, 0.8% SDS), followed
by extraction with one-third volume of saturated NaCl and precipitation
in an equal volume of isopropanol. EcoRV fragments were
separated on a 0.66% agarose gel and detected by Southern analysis
using the indicated probe (Fig. 1A). ATR-disrupted lines 1 and
2 are derived from J1 and D3 ES cell lines, respectively. PCR
genotyping was performed using a common primer, 121 bp 5' of the
initiating methionyl codon in exon 1 (5'-ttccgggaggagaattttggac-3') in combination with primers discriminating wild-type exon 1-containing alleles
(5'-cggcgactcgaagctggcgacgacgc-3') and knockout alleles
encoding the 3' end of the neomycin resistance gene
(5'-cagcgcatcgccttctatcgccttcttgac-3'). PCR was performed in
25-µl reactions with 1× PCR buffer (Boehringer Mannheim), 1.25 units of Taq polymerase, and 2% DMSO. Temperature cycling
conditions were (1) 94°C for 4 min, (2) 94°C for 1 min, (3)
62°C for 2.5 min, and (4) 72°C for 2.5 min, cycling 33 times to
step 2. Poly (A)+ mRNA from ES cells and day 14.5 MEFs was isolated,
subjected to Northern blot analysis, and probed with the full-length
human ATR cDNA (Cimprich et al. 1996
). Normalization was
performed upon subsequent probing with the full-length cDNAs for
FRAP (Brown et al. 1994
) and
-actin
(Clontech). Levels of mRNA were quantitated by PhosphorImager readout
(Molecular Dynamics), and 95% confidence intervals for the average
reduction of normalized ATR mRNA levels were calculated by
Student's t-test.
Survival of and tumors in
ATR+/
mice
ATR+/
and
ATM+/
of 129Sv and
C57BL/6 mixed background were intercrossed to produce
populations of ATR+/
,
ATR+/
ATM+/
,
and ATM+/
mice. Mice suffering
from severe fighting wounds (~10%) were excluded from further
study. The percentages of deceased and euthanized mice from
ATR+/
and
ATR+/
ATM+/
populations were compared to that of
ATM+/
by Kaplan-Meier analysis,
and log-rank P values were calculated (Biostat 2000, Cupertino, CA). Individual comparison of
ATR+/
and
ATR+/
ATM+/
survival with ATM+/
survival was
significant to P values of 0.067 and 0.097, respectively. Histopathology on formalin-fixed tissues was performed by the Research
Animal Diagnostic and Investigative Laboratory (Columbia, MO). Test
significance of difference in tumor incidence for animals autopsied
79-89 weeks of age was calculated by one tailed z-test.
Cultured blastocysts and TUNEL assays
Blastocysts were flushed from the uterus of
ATR+/
females 3.5 days p.c. and
washed five times in M2 media (Sigma) or PBS containing 5% FBS.
Blastocysts were cultured for the times indicated in 50 µl (Fig.
2A) or 15 µl (Fig. 2B) of DMEM containing 15% FBS, 100 µM
-mercaptoethanol, 2 mM glutamine, 100 µM nonessential amino acids, and 1×
penicillin/streptomycin (GIBCO-BRL). Z-DEVD-FMK (200 µM) or vehicle was added after 24 and 48 hr (72-hr time
point) of culture. At 200 µM, Z-DEVD-FMK has been shown
to completely prevent Fas-induced apoptosis in human cells without
affecting cellular proliferation (Longthorne and Williams 1997
). For
TUNEL assay, blastocysts were fixed at the indicated times in 3%
paraformaldyhyde/PBS for 30 min. Permeabilization and
TUNEL assays were performed using the In Situ Cell Death Detection Kit,
Fluorescein (Boehringer Mannheim) as per the manufacturer's
instructions. For PCR genotyping, DNA was prepared by incubation of
individual blastocysts with 1.5 µl of NSPK buffer [300
µg/ml proteinase K (Boehringer Mannheim), 100 mM KCl, 20 mM Tris at pH 8.0, 4 mM
MgCl2, 0.9% NP-40, 0.9% Triton X-100] for 4 hr at 60°C,
followed by incubation at 90°C for 30 min. The entire DNA isolate
was used directly for PCR, which was performed as described for Figure
1C. PCR products were then Southern blotted and probed with a
32P end-labeled internal primer common to both wild-type and
mutant PCR products (5'-gacctcgcggggctccgtcga-3'). Hybridized
products were detected by autoradiography.
Preparation of mitotic spreads and genotyping
Blastocysts were grown in 96-well round-bottom plates as described (Fig. 2A) and treated with 200 µM Z-DEVD-FMK or vehicle (0.1% DMSO) after 24 and 48 hr in culture. At 48 hr in culture, blastocysts were treated with 2.5 µM nocodazole for 6 hr and subsequently processed for preparation of mitotic spreads. To suspend cells, blastocysts were washed twice in PBS and trypsinized in 30 µl of 0.25% trypsin/1 mM EDTA (GIBCO-BRL). Trypsin was then neutralized with 150 µl of culture media and, cells were tritriated and transferred to 200-µl micocentrifuge tubes. At this step, 60 µl of the cell suspension was transferred to a separate tube for PCR analysis (below). The remaining 120-µl cell suspension was washed once in PBS (250 g centrifugation), resuspended in 75 mM KCl, and incubated at room temperature for 20 min. Cells were then centrifuged at 500g, resuspensed in ice-cold 3:1 (vol/vol) methanol/acetic acid fixative, incubated at 4°C for 10 min, and centrifuged at 650g. The fixation steps were repeated once, and cells were resuspended in 15 µl of fixative and dropped onto prewarmed (37°C) glass slides. Slides were stained with Hoechst or Giemsa, and mitotic and interphase cells were counted. Confidence intervals (95%) were calculated by Student's t-test. For genotyping, cells (60 µl, above) were washed five times with PBS (250g centrifugation). All centrifugation steps in these procedures were for 5 min. The final cell pellet was resupended in 1.5 µl of NSPK buffer, and DNA was isolated and PCR genotyped as described above.
| |
Acknowledgments |
|---|
We are indebted to M. Scott and J. Harrison for invaluable
assistance in the generation of knockout cells and chimeric
ATR+/
mice. We also thank the
following people for reagents, technical training, and helpful
discussions: K. Cimprich, S. Schreiber, A. Koleske, C. Lois, J. Pomerantz, Y. Yamanashi, J. Baer, I. Stancovski, H. Chang, Y. Xu, S. Cherry, M. Meffert, and M. Porteus. We are grateful to P. Svec and L. Newman for laboratory assistance and L. Anonuevo, K. Owler, B. Kennedy,
and S. Pease. E.J.B. was supported by a fellowship from the Cancer
Research Institute.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
[Key Words: ATR; ATM; p53; embryonic lethality; chromosome breaks]
Received November 16, 1999; revised version accepted January 10, 2000.
1 Corresponding author.
E-MAIL baltimo{at}caltech.edu; FAX (626) 585-9495.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Yan, X.-P. Yang, Y.-S. Kim, and A. M. Jetten RAP80 Responds to DNA Damage Induced by Both Ionizing Radiation and UV Irradiation and Is Phosphorylated at Ser205 Cancer Res., June 1, 2008; 68(11): 4269 - 4276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Burrows and S. J. Elledge How ATR turns on: TopBP1 goes on ATRIP with ATR Genes & Dev., June 1, 2008; 22(11): 1416 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mordes, G. G. Glick, R. Zhao, and D. Cortez TopBP1 activates ATR through ATRIP and a PIKK regulatory domain Genes & Dev., June 1, 2008; 22(11): 1478 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulkarni and K. C. Das Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L998 - L1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sivasubramaniam, X. Sun, Y.-R. Pan, S. Wang, and E. Y.-H.P. Lee Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1 Genes & Dev., March 1, 2008; 22(5): 587 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Entezam and K. Usdin ATR protects the genome against CGG{middle dot}CCG-repeat expansion in Fragile X premutation mice Nucleic Acids Res., February 11, 2008; 36(3): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Toledo, M. Murga, P. Gutierrez-Martinez, R. Soria, and O. Fernandez-Capetillo ATR signaling can drive cells into senescence in the absence of DNA breaks Genes & Dev., February 1, 2008; 22(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J.H. Arlander, B. T. Greene, C. L. Innes, and R. S. Paules DNA Protein Kinase Dependent G2 Checkpoint Revealed following Knockdown of Ataxia-Telangiectasia Mutated in Human Mammary Epithelial Cells Cancer Res., January 1, 2008; 68(1): 89 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H. Zhang, C. Zhao, and Z. A. Ma The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR J. Cell Sci., December 1, 2007; 120(23): 4134 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wood, N. Singh, G. Mer, and J. Chen MCPH1 Functions in an H2AX-dependent but MDC1-independent Pathway in Response to DNA Damage J. Biol. Chem., November 30, 2007; 282(48): 35416 - 35423. [Abstract] [Full Text] [PDF] |
||||